Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.

Campbell R, Costa DSJ, Stockler MR, Lee YC, Ledermann JA, Berton D, Sehouli J, Roncolato FT, Connell RO, Okamoto A, Bryce J, Oza AM, Avall-Lundqvist E, Berek JS, Lanceley A, Joly F, Hilpert F, Feeney A, Kaminsky MC, Diamante K, Friedlander ML, King MT, GCIG Symptom Benefit Group

Open source

DOI: 10.1016/j.ygyno.2022.05.024
Published: 2022 Aug
Container: Gynecologic oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2022.05.024,
  title = {Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.},
  author = {Campbell R and Costa DSJ and Stockler MR and Lee YC and Ledermann JA and Berton D and Sehouli J and Roncolato FT and Connell RO and Okamoto A and Bryce J and Oza AM and Avall-Lundqvist E and Berek JS and Lanceley A and Joly F and Hilpert F and Feeney A and Kaminsky MC and Diamante K and Friedlander ML and King MT and GCIG Symptom Benefit Group},
  year = {2022},
  journal = {Gynecologic oncology},
  doi = {10.1016/j.ygyno.2022.05.024},
  url = {https://doi.org/10.1016/j.ygyno.2022.05.024}
}

RIS

TY  - JOUR
TI  - Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
AU  - Campbell R
AU  - Costa DSJ
AU  - Stockler MR
AU  - Lee YC
AU  - Ledermann JA
AU  - Berton D
AU  - Sehouli J
AU  - Roncolato FT
AU  - Connell RO
AU  - Okamoto A
AU  - Bryce J
AU  - Oza AM
AU  - Avall-Lundqvist E
AU  - Berek JS
AU  - Lanceley A
AU  - Joly F
AU  - Hilpert F
AU  - Feeney A
AU  - Kaminsky MC
AU  - Diamante K
AU  - Friedlander ML
AU  - King MT
AU  - GCIG Symptom Benefit Group
PY  - 2022
JO  - Gynecologic oncology
DO  - 10.1016/j.ygyno.2022.05.024
UR  - https://doi.org/10.1016/j.ygyno.2022.05.024
ER  -

APA

R, C., DSJ, C., MR, S., YC, L., JA, L., D, B., J, S., FT, R., RO, C., A, O., J, B., AM, O., E, A., JS, B., A, L., F, J., F, H., A, F., MC, K., K, D., ML, F., MT, K., & Group, G. S. B. (2022). Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.. Gynecologic oncology. https://doi.org/10.1016/j.ygyno.2022.05.024

Source records

pubmed · retrieved 2026-09-25T20:25:59.209Z